Literature DB >> 18221996

Unrelated umbilical cord blood transplantation as salvage treatment for engraftment failure following autologous stem cell transplantation.

Roland Fenk1, Frank Neumann, Barbara Fenk, Leilani Ruf, Fabian Zohren, Nelly-Nancy Safaian, Rainer Haas, Guido Kobbe.   

Abstract

We report a case of a patient with multiple myeloma and engraftment failure after high-dose therapy with autologous stem cell transplantation. After rescue treatment with G-CSF and back-up reinfusion of autologous stem cells failed, allogeneic umbilical cord blood transplantation resulted in neutrophil engraftment on day +16 and a 57 months lasting complete remission. This case report shows that umbilical cord blood transplantation is a rescue option after engraftment failure of autologous transplantation, which is available for 99% of patients due to the less stringent HLA matching criteria. Moreover, the prompt availability allows transplantation to be performed at an optimal time.

Entities:  

Mesh:

Year:  2008        PMID: 18221996     DOI: 10.1016/j.leukres.2007.12.003

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  1 in total

1.  Outcomes of unrelated cord blood transplantation in patients with multiple myeloma: a survey on behalf of Eurocord, the Cord Blood Committee of Cellular Therapy and Immunobiology Working Party, and the Chronic Leukemia Working Party of the EBMT.

Authors:  Annalisa Paviglianiti; Erick Xavier; Annalisa Ruggeri; Patrice Ceballos; Eric Deconinck; Jan J Cornelissen; Stephanie Nguyen-Quoc; Natacha Maillard; Guillermo Sanz; Pierre-Simon Rohrlich; Laurent Garderet; Fernanda Volt; Vanderson Rocha; Nicolaus Kroeger; Eliane Gluckman; Nathalie Fegueux; Mohamad Mohty
Journal:  Haematologica       Date:  2016-05-26       Impact factor: 9.941

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.